Compounds > 3'-hydroxymethyl-4-(dimethylamino)azobenzene
Page last updated: 2024-12-06

3'-hydroxymethyl-4-(dimethylamino)azobenzene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID108204
MeSH IDM0100730

Synonyms (15)

Synonym
benzyl alcohol, m-((p-dimethylaminophenyl)azo)-
benzenemethanol, 3-((4-(dimethylamino)phenyl)azo)-
m-((p-dimethylaminophenyl)azo)benzyl alcohol
3-((p-dimethylamino)phenylazo)benzyl alcohol
3-((4-(dimethylamino)phenyl)azo)benzenemethanol
3'-hydroxymethyl-4-(dimethylamino)azobenzene
brn 1821443
35282-69-0
benzenemethanol,3-[2-[4-(dimethylamino)phenyl]diazenyl]-
DTXSID801210636
3-[2-[4-(dimethylamino)phenyl]diazenyl]benzenemethanol
AMY39924
(3-((4-(dimethylamino)phenyl)diazenyl)phenyl)methanol
[3-[[4-(dimethylamino)phenyl]diazenyl]phenyl]methanol
AKOS040749956
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (71.43)18.7374
1990's2 (28.57)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
methyldimethylaminoazobenzene
Methyldimethylaminoazobenzene: A very potent liver carcinogen.. 3-methyl-4'-dimethylaminoazobenzene : A member of the class of azobenzenes that is azobenzene in which one of the phenyl groups is substituted at position 3 by a methyl group, while the other is substituted at position 4 by a dimethylamino group. It is a potent liver carcinogen.		3.3570
p-dimethylaminoazobenzene
p-Dimethylaminoazobenzene: A reagent used mainly to induce experimental liver cancer. According to the Fourth Annual Report on Carcinogens (NTP 85-002, p. 89) published in 1985, this compound may reasonably be anticipated to be a carcinogen. (Merck, 11th ed)		3.0650azobenzenes
tyrosine
Tyrosine: A non-essential amino acid. In animals it is synthesized from PHENYLALANINE. It is also the precursor of EPINEPHRINE; THYROID HORMONES; and melanin.. tyrosine : An alpha-amino acid that is phenylalanine bearing a hydroxy substituent at position 4 on the phenyl ring.		210amino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
tyrosine		EC 1.3.1.43 (arogenate dehydrogenase) inhibitor;
fundamental metabolite;
micronutrient;
nutraceutical
deuterium
Deuterium: The stable isotope of hydrogen. It has one neutron and one proton in the nucleus.		1.9610dihydrogen
ConditionIndicatedRelationship StrengthStudiesTrials
Hepatocellular Carcinoma
[description not available]		02.3820
Cancer of Liver
[description not available]		02.3820
Carcinoma, Hepatocellular
A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.		02.3820
Hyperplasia
An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.		01.9610
Liver Neoplasms
Tumors or cancer of the LIVER.		02.3820
Cocarcinogenesis
The combination of two or more different factors in the production of cancer.		01.9610
Experimental Hepatoma
[description not available]		02.3820